ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,738 Cr | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr | ₹-1,108 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ALKEM LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-1,738 Cr |
Mar2024 | ₹-1,515 Cr |
Mar2023 | ₹-1,303 Cr |
Mar2022 | ₹-1,309 Cr |
Mar2021 | ₹-1,108 Cr |
How is Deferred Tax Assets / Liabilities of ALKEM LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-1,738 Cr | Negative | |
Mar2024 | ₹-1,515 Cr | Negative | |
Mar2023 | ₹-1,303 Cr | Negative | |
Mar2022 | ₹-1,309 Cr | Negative | |
Mar2021 | ₹-1,108 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹64,302.3 Cr | -0.9% | 6.5% | -6.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,594.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,722.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹127,508.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,225.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | -0.9% |
6.5% |
-6.9% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses